{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Dihydropyridine NPY antagonists: cyanoguanidine derivatives", "item": "https://www.patentleaderboard.com/patent/6001836"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydropyridine NPY antagonists: cyanoguanidine derivatives

Dihydropyridine NPY antagonists: cyanoguanidine derivatives

US Patent 6001836 · Granted Dec 14, 1999

Estimated economic value: $860,926,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indazole carboxamides as kinase inhibitors2025
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
Aminotriazolopyridines as kinase inhibitors2024
Oxazole TRPML1 agonists and uses thereof2024
Naphthyridinone compounds useful as T cell activators2024
Substituted naphthyridinone compounds useful as T cell activators2023
Aminopyrrolotriazines as kinase inhibitors2023
Triterpenoids with HIV maturation inhibitory activity2022
Substituted pyridine and pyrazine compounds as PDE4 inhibitors2022
Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitors2021
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors2021
Substituted naphthyridinone compounds useful as T cell activators2021